Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1/2A Dose Escalation Study in CLL, SLL or NHL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01994382
Recruitment Status : Active, not recruiting
First Posted : November 25, 2013
Last Update Posted : October 6, 2020
Sponsor:
Information provided by (Responsible Party):
Portola Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020